Author Helps Others Through Life’s Unavoidable Obstacles with the Help of Cannabis, Cats, and Creativity
August 24, 2020 10:03 ET
|
XlibrisUS
QUARTZ HILL, CA, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Inspired by the curiosity of his cats and life’s unavoidable obstacles, author Don Agey uses emotions pulled from unexplored and deeply buried...
aTyr Pharma Announces Second Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trial Programs
August 13, 2020 16:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan
August 11, 2020 07:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
The Poet Dena shares poetry collection about living with and healing from depression and emotional trauma
July 02, 2020 01:28 ET
|
AuthorHouse
TORONTO, July 02, 2020 (GLOBE NEWSWIRE) -- The Poet Dena wanted to share her journey of recovery from depression and emotional trauma she experienced in her life. This objective prompted her to...
aTyr Pharma Presents Preclinical Research Showing NRP2 Antibody Effects in Triple-Negative Breast Cancer at the 2020 AACR Virtual Annual Meeting II
June 22, 2020 08:00 ET
|
aTyr Pharma, Inc.
Poster details data from aTyr’s preclinical, domain specific Neuropilin-2 (NRP2) antibody program showing antibodies may increase sensitivity to chemotherapy in triple-negative breast cancer. SAN...
aTyr Pharma Highlights New Literature Implicating Neuropilin Pathway In SARS-CoV-2 Infection
June 17, 2020 17:00 ET
|
aTyr Pharma, Inc.
Discovery that Neuropilin b1 domain acts as a binding site for SARS-CoV-2 Spike protein and aids viral entry. Lead therapeutic candidate, ATYR1923, modulates Neuropilin pathway to dampen inflammatory...
aTyr Pharma Announces Dosing of First Patient in Phase 2 Trial of ATYR1923 in COVID-19 Patients with Severe Respiratory Complications
June 15, 2020 07:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, June 15, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...
Book follows an African girl who saves a lion cub but must deal with the loss when the cub is returned to the wild
June 15, 2020 01:00 ET
|
AuthorHouseUK
MEYERTON, South Africa, June 15, 2020 (GLOBE NEWSWIRE) -- Debuting author Thabitha Mathabatha announces her entry to the publishing scene with the release of “The Brave Little African Girl”...
Author Showcases Life After Death in New Book
May 26, 2020 12:03 ET
|
iUniverse
Norfolk, VA, May 26, 2020 (GLOBE NEWSWIRE) -- It had to be destiny that brought Dr. Cynthia Bischoff and her client, Lily, together. Lily was a gentle and loving soul who suffered the despair and...
aTyr Pharma to Present Poster at the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II
May 20, 2020 08:03 ET
|
aTyr Pharma, Inc.
SAN DIEGO, May 20, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological...